NASDAQ:RNAC

Cartesian Therapeutics Stock Forecast

etoro logo Buy RNAC
*Your capital is at risk
$8.13
-0.0500 (-0.611%)
At Close: Jul 21, 2026
AI Analysis AI Analysis of RNAC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RNAC to Watchlist?
Some Reasons Why To Add RNAC:
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong return on equity of 194.1%
  • Consistently positive technical signals over the last month
PDF

Cartesian Therapeutics, Inc. stock price down 0.611% on Tuesday
(Updated on Jul 21, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026 Loss -2.40%

The Cartesian Therapeutics, Inc. stock price fell by -0.611% on the last day (Tuesday, 21st Jul 2026) from $8.18 to $8.13. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 4.54% from a day low at $7.93 to a day high of $8.29. The price has fallen in 8 of the last 10 days and is down by -19.1% for this period. Volume has increased on the last day by 47 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 152 thousand shares were bought and sold for approximately $1.23 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.88% during the next 3 months and, with a 90% probability hold a price between $9.87 and $15.18 at the end of this 3-month period.

RNAC Signals & Forecast

There are few to no technical positive signals at the moment. The Cartesian Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.40 and $8.70. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -23.23%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Cartesian Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Cartesian Therapeutics, Inc. stock

Cartesian Therapeutics, Inc. finds support from accumulated volume at $8.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.360 between high and low, or 4.54%. For the last week, the stock has had daily average volatility of 5.99%.

Cartesian Therapeutics, Inc. is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RNAC) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Cartesian Therapeutics, Inc. to open at $8.12, and during the day (based on 14 day Average True Range), to move between $7.76 and $8.50, which gives a possible trading interval of +/-$0.736 (+/-9.48%) up or down from last closing price. If Cartesian Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 9.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.06 (0.86%) than the resistance at $9.42 (15.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cartesian Therapeutics, Inc. stock A Buy?

The Cartesian Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Cartesian Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.402 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 22, 2026 - $8.12 ( 0.164%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RNAC Performance

Trading levels for RNAC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.48 4.26%
R2 8.34 2.57%
R1 8.25 1.53%
Price 8.13
S1 7.98 -1.86%
S2 7.89 -2.90%
S3 7.76 -4.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.88 21.53%
R2 9.51 16.97%
R1 9.42 15.87%
Price 8.13
S1 8.06 -0.86%
S2 7.43 -8.61%
S3 6.85 -15.74%

FAQ

What is the symbol for Cartesian Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Cartesian Therapeutics, Inc. is RNAC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cartesian Therapeutics, Inc. Stock?
The Cartesian Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Cartesian Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Cartesian Therapeutics, Inc. Stock?
Cartesian Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cartesian Therapeutics, Inc. Stock.

What's the current price of Cartesian Therapeutics, Inc. Stock?
As of the end of day on the Jul 21, 2026, the price of an Cartesian Therapeutics, Inc. (RNAC) share was $8.13.

What is the 52-week high and low for Cartesian Therapeutics, Inc. Stock?
The 52-week high for Cartesian Therapeutics, Inc. Stock is $14.56 and the 52-week low is $5.60.

What is the market capitalization of Cartesian Therapeutics, Inc. Stock?
As of the Jul 21, 2026, the market capitalization of Cartesian Therapeutics, Inc. is 238.872M.

When is the next earnings date for Cartesian Therapeutics, Inc.?
The upcoming earnings date for Cartesian Therapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.35% Jul 13
JLL
$299.78
8.73% Jun 24
NMRK
$15.02
3.26% Jun 24
NESR
$25.07
8.62% Jun 23
CAG
$13.43
9.20% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE